Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

680 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic Hypotension: The PARAGLIDE-HF Trial.
Fudim M, Cyr DD, Ward JH, Hernandez AF, Lepage S, Morrow DA, Sharma K, Claggett BL, Starling RC, Velazquez EJ, Williamson KM, Desai AS, Zieroth S, Solomon SD, Braunwald E, Mentz RJ; PARAGLIDE-HF Investigators. Fudim M, et al. Among authors: starling rc. J Card Fail. 2024 May 25:S1071-9164(24)00187-8. doi: 10.1016/j.cardfail.2024.04.030. Online ahead of print. J Card Fail. 2024. PMID: 38802053
Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.
Morrow DA, Velazquez EJ, Desai AS, DeVore AD, Lepage S, Park JG, Sharma K, Solomon SD, Starling RC, Ward JH, Williamson KM, Zieroth S, Hernandez AF, Mentz RJ, Braunwald E. Morrow DA, et al. Among authors: starling rc. J Am Coll Cardiol. 2024 Mar 26;83(12):1123-1132. doi: 10.1016/j.jacc.2024.01.027. J Am Coll Cardiol. 2024. PMID: 38508844 Free article. Clinical Trial.
Patient and Provider Factors Associated With Initiating Sodium-Glucose Cotransporter-2 Inhibitors (SGTL2is) Following FDA Approval for Heart Failure With Preserved and Mildly Reduced Ejection Fraction.
Martyn T, Saef J, Bansal A, Martinez KA, Block-Beach H, Hohman J, Kapadia SR, Desai MY, Estep JD, Albert NM, Starling RC, Tang WHW. Martyn T, et al. Among authors: starling rc. J Card Fail. 2024 Apr;30(4):630-632. doi: 10.1016/j.cardfail.2024.01.006. Epub 2024 Feb 16. J Card Fail. 2024. PMID: 38367905 No abstract available.
Back to the basics: The need for an etiological classification of chronic heart failure.
Triposkiadis F, Xanthopoulos A, Drakos SG, Boudoulas KD, Briasoulis A, Skoularigis J, Tsioufis K, Boudoulas H, Starling RC. Triposkiadis F, et al. Among authors: starling rc. Curr Probl Cardiol. 2024 Apr;49(4):102460. doi: 10.1016/j.cpcardiol.2024.102460. Epub 2024 Feb 10. Curr Probl Cardiol. 2024. PMID: 38346611 Review.
Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial.
Litwin SE, Komtebedde J, Seidler T, Borlaug BA, Winkler S, Solomon SD, Eicher JC, Mazimba S, Khawash R, Sverdlov AL, Hummel SL, Bugger H, Boenner F, Hoendermis E, Cikes M, Demers C, Silva G, van Empel V, Starling RC, Penicka M, Cutlip DE, Leon MB, Kitzman DW, van Veldhuisen DJ, Shah SJ; REDUCE LAP-HF Investigators and Research Staff. Litwin SE, et al. Among authors: starling rc. Eur J Heart Fail. 2024 Jan;26(1):177-189. doi: 10.1002/ejhf.3092. Epub 2023 Dec 7. Eur J Heart Fail. 2024. PMID: 37989800
680 results